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Crohn’s disease, PI predicted relapse in 76% of patients, 
and the probability of relapse increased with increasing PI. 
Several attempts have been made to predict the course of 
Crohn’s disease. Concentrations of acute phase proteins in 
the plasma have been suggested,12 but in only one study was 
a reliable predictive index established by combining the 
results of several laboratory tests.13 The PI test differs from 
other indices because it is not based on concentrations of 
proteins in plasma, but rather represents functional changes 
in the intestinal mucosa. The test may be useful to assess the 
effects of treatment and to follow the course of the disease. 
Our results also suggest that increases in IP may occur early 
in relapses of Crohn’s disease, or even initiate them: 
increased permeability may lead to the absorption of 
endotoxin and lipopolysaccharides from the lumen. Both 
these substances are potent stimulators of acute-phase 
reactions and liberation of interleukin-6, which has been 
shown to be an important mediator of inflammation in 
Crohn’s disease.14 What causes the increase in permeability, 
however, is unknown.
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Primary immunodeficiency disorders can 
predispose to certain malignancies but hitherto no 
such relation has been established for X-linked 
agammaglobulinaemia (XLA). We have diagnosed 
rapidly progressive colorectal cancer in 3 unrelated 
young adults with XLA. We could find no 
explanation for the tumours. Since the calculated 
incidence of rectosigmoid cancer is increased 30- 
fold in patients with XLA, we advise the screening of 
these individuals, and perhaps people with other 
agammaglobulinaemias, for colorectal cancer.
Lancet 1993; 341:1439-40.
Gastrointestinal ailments are common in patients with 
primary agammaglobulinaemia.1 Intestinal infections with 
Giardia lamb lia, Campylobacter jejitni, and Salmonella spp 
are frequent.1,2 Giardiasis may lead to malabsorption, while 
C jejuni infection may result in recurrent fever.3,4 In 
late-onset agammaglobulinaemia (LOA), lymphonodular 
hyperplasia is common; the aetiology and pathogenesis of 
this abnormality are not known. Antral gastritis with 
abnormal gastrin production capacity is also a common
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finding in people with LOA,5 whose risk of developing 
gastric cancer is some 47-fold greater than that of the normal 
population.6 Malignant lymphoma is also 30 times more 
common in people with LOA.6 An increased risk of 
developing cancer is less well established for the other 
common types of agammaglobulinaemia (X-linked [XLA] 
and early-onset agammaglobulinaemia).1,6“9 Here we 
describe 3 unrelated patients with XLA who developed 
colorectal cancer at an early age.
Patient A  was bom in 1959 and agammaglobulinaemia 
was diagnosed at an early age. Our diagnosis of XLA was 
based on family history, absence of B lymphocytes, and very 
low serum concentrations of immunoglobulins (IgG
0-6 g/L, IgA and IgM not detectable). 3 brothers with the 
same disorder had died of pulmonary complications, and an 
affected male cousin survives. There was no family history 
of colorectal or other cancers. The patient did well on 
intramuscular gammaglobulin until October, 1984, when he 
complained of abdominal distension, cramps, and 
diarrhoea. During the next few months he lost 16 kg and he 
was cachectic when admitted to hospital in March, 1985. He 
was pale with a pulse rate of 100/min, but there were no 
other abnormalities on physical examination. He had a 
haemoglobin concentration of 6 9 mmol/L, microcytic red 
blood cells, serum iron concentration of 1 mmol/L, and 
thrombocytosis (760 x 109/L). Serum albumin and IgG 
were 30 g/L and 1-3 g/L, respectively. A jejunal biopsy 
revealed complete villus atrophy, but no G lamblia infection.
2 weeks after admission an acute abdomen with 
hyperperistalsis developed. An abnormal mass was palpated 
on rectal examination. Subphrenic gas was seen on a chest 
radiograph. At laparotomy, a nonresectable rectal 
carcinoma was found together with a perforation and 
carcinomatous peritonitis. An adenocarcinoma was
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diagnosed. The patient died a week later. Necropsy 
confirmed widespread metastatic rectal carcinoma.
Patient B was bom in 1961 into a large family with a 
pattern of X-linked inheritance of agammaglobulinaemia 
(pedigree 66-8 in refs 10 and 11), but no history of colorectal 
cancer. There was almost no immunoglobulin in his blood 
and B lymphocytes were undetectable. He had bronchitis, 
recurrent bacteraemia, and skin lesions due to C jejuni, and 
had slight cirrhosis of the liver after hepatitis B infection. 
The C jejuni infection had been cured with imipenem and 
plasma infusions.4 In December, 1990, diarrhoea occurred, 
for which no causative microorganism could be found. 7 
months later, the patient was admitted with abdominal 
cramps, persistent diarrhoea, and weight loss. He had seen 
blood in his stools. Physical examination was unremarkable 
apart from a palpable mass on rectal examination.
The haemoglobin concentration was 7-7 mmol/L. 
Barium enema and sigmoidoscopy revealed a constricting 
rectal tumor 8 cm from the anal ring surrounded by multiple 
adenomas (0-5-2 cm diameter). Histology was consistent 
with adenocarcinoma. The tumour was resected but a 
metastasis was found in the liver. Despite chemotherapy, the 
cancer progressed rapidly and the patient died in December, 
1991. Necropsy was not done.
Patient C is a 36-year-old man, diagnosed as having XLA 
on grounds of absent B lymphocytes and genetic studies 
(pedigree B2 in refs 10 and 11). 2 of his 3 brothers with XLA 
have died of pulmonary complications. There was no family 
history of colorectal or other cancers. Recurrent infection of 
the respiratory tract had led to mild bronchiectasis. The 
patient also had recurrent prostatitis and epididymitis, for 
which he had had an epididymectomy. His current illness 
started in May, 1992, with diarrhoea and abdominal cramps. 
At first these symptoms were attributed to antimicrobial 
therapy for a respiratory infection. He had seen traces of 
blood in his stools, which were found to contain C jejuni. On 
rectal examination, there was a palpable mass, which on 
histological examination proved to be an adenocarcinoma. 
In addition, a small adenomatous polyp was found in the 
rectum. At laparotomy, a massive nonresectable tumour was 
found infiltrating the adjacent structures.
Were these cancers coincidental or were they the result of 
XLA? There has been a report of multiple colorectal 
neoplasms in a 22-year-old man with congenital hypo- 
gammaglobulinaemia.10 Kinlen et al6 found 2 patients with 
XLA and colon cancer in their survey of cancer in patients 
with hypogammaglobulinaemia. The registry of the Dutch 
Working Party for Primary Immunodeficiency has enrolled 
52 X-linked agammaglobulinaemia patients, since no other 
cases of rectal or colonic cancer have been found so far in this 
group, the observed risk is 3/52 with a mortality of 2/52. The 
expected number of patients with rectosigmoid cancer and 
the expected number of deaths from this type of cancer can 
be calculated from data of the Netherlands Cancer Registry 
by multiplying the 5-year age-specific incidence and 
mortality rates for men by the corresponding person-years 
at risk. Incidence of rectosigmoid cancer for people with 
XLA is therefore 30-fold and mortality 59-fold greater than 
that of the normal population.
We are now seeing the first generation of patients with 
XLA who reach adulthood. This may be why an increased 
risk of cancer of the large bowel has not been noted 
previously. Patients with other types of agamma­
globulinaemia might also be at risk, although other 
workers1,6 did not find any such cancer in more than 220 
patients with LOA.
What pathogenetic mechanisms could underly the 
development of these cancers? Cellular immunity in XLA is 
normal, but the absence of a functional mucosal-humoral 
immune system may lead to alterations in intestinal 
microflora. Increased susceptibility to any pathogens 
present in the gut may lead to chronic inflammation and 
dysplasia. Multiple courses of antibiotics might further 
modify the microflora, especially those organisms 
producing potentially carcinogenic substances. Intimate 
contact between those substances and the bowel epithelium 
would be possible, owing to the deficiency in mucosal 
immunoglobulins. The patient reported by Adachi et al11 
had 20 adenomatous polyps and 9 adenocarcinomas in his 
colon. Histological examination of the resected bowel of 
patient B also showed multiple foci of adenomatosis. 
Therefore, there may be increased susceptibility to 
colorectal cancer. Long-term abdominal symptoms or 
irregular bowel movements should not be dismissed as the 
benign gastrointestinal ailments to which patients with 
XLA are prone. Infection with an enteric pathogen such as 
Cjejuni may not be wholly responsible, and a more extensive 
diagnostic approach (endoscopic examination or barium 
enema) is indicated.
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